Table 1 General characteristics of patients.
From: Salivary cytokine profile in patients with ischemic stroke
Control n = 25 | Stroke n = 25 | p value | |||
|---|---|---|---|---|---|
Mean ± SD | 95% CI | Mean ± SD | 95% CI | ||
Sex (male/female) | 12/13 | 12/13 | > 0.9999 | ||
Age | 63.52 ± 8.545 | 59.99 – 67.05 | 63.52 ± 8.545 | 59.99–67.05 | > 0.9999 |
Cognitive and physical functional status | |||||
ACE III | 97.24 ± 1.422 | 96.65 – 97.83 | 69.8 ± 22.97 | 60.32–79.28 | < 0.0001 |
BI | 20 ± 0 | 20—20 | 10.92 ± 3.662 | 9.408–12.43 | < 0.0001 |
BBS | 55.52 ± 0.5099 | 55.31 – 55.73 | 31 ± 16.27 | 24.28–37.72 | < 0.0001 |
FIM | 125.3 ± 0.6904 | 125 – 125.6 | 86.88 ± 30.31 | 74.37–99.39 | < 0.0001 |
Comorbidities | |||||
Hypertension n (%) | 18 (72) | 17 (68) | > 0.9999 | ||
Diabetes n (%) | 4 (16) | 4 (16) | > 0.9999 | ||
Epilepsy n (%) | 4 (16) | 3 (12) | > 0.9999 | ||
Arteriosclerosis n (%) | 7 (28) | 8 (32) | > 0.9999 | ||
Limb thrombosis n (%) | 2 (8) | 2 (8) | > 0.9999 | ||
Atrial fibrillation n (%) | 3 (12) | 3 (12) | > 0.9999 | ||
Drugs | |||||
< 5 drugs/day n (%) | 10 (40) | 9 (36) | > 0.9999 | ||
≥ 5 drugs/day n (%) | 15 (60) | 16 (64) | > 0.9999 | ||
